Hormonal health

Watchful Waiting for Fibroids: When It's Reasonable

Save

Watching fibroids without treatment is safe for many women when the fibroids cause no or minimal symptoms, since most grow slowly and shrink after menopause. Periodic check-ins track size and symptoms, and the plan moves toward treatment if heavy bleeding, pelvic pressure, or fast growth develops.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Is it safe to leave fibroids untreated?

Leaving fibroids untreated is medically reasonable when they cause no symptoms or only mild ones. Fibroids are noncancerous growths of the uterine muscle, and the vast majority stay benign — fewer than 1 in 1,000 turn out to be a cancer called leiomyosarcoma 2. According to the Office on Women's Health, fibroids are very common, and by age 50 as many as 7 or 8 in 10 women may have at least one, yet most never cause a problem 1.

Because a fibroid that is not bleeding, painful, or causing pressure rarely poses a danger, expectant management — watching rather than treating — is an accepted first choice in clinical guidelines 2. Observing does not let a silent problem worsen out of view, because scheduled reassessment is part of the plan. The goal is to act when there is a reason to, and to spare you treatment you may never need.

Who is a good candidate for watchful waiting?

Good candidates for watchful waiting are women whose fibroids are small, slow-growing, and not disrupting daily life. Expectant management suits someone with mild or no symptoms, stable bleeding, and no anemia 2. It can also fit women nearing menopause, since falling estrogen often causes fibroids to shrink on their own 1.

Life stage matters here: fibroids typically appear during the reproductive years, may enlarge in the 40s during the perimenopausal transition when hormones fluctuate, and usually stabilize or regress after periods stop 1. A clinician weighs your symptoms, the fibroids' size and location, any plans for pregnancy, and how close you are to menopause before recommending a wait-and-see path. Someone with fast growth, worsening anemia, or fertility concerns is usually steered toward earlier action.

How often should fibroids be monitored?

Monitoring usually means periodic check-ins rather than a fixed test schedule. Many clinicians reassess symptoms every 6 to 12 months — an interval chosen case by case rather than fixed by any guideline — using a pelvic exam and, when useful, an ultrasound to track size 2. There is no single mandated interval, since the right rhythm depends on how the fibroids behave over time.

Between visits, tracking your cycle and any new pressure or bleeding helps, and comparing notes with heavy menstrual bleeding causes can sharpen what you report to your clinician. Because heavy flow can quietly lower iron, some clinicians check a blood count or ferritin during follow-up 4. Understanding what a ferritin test measures makes those numbers easier to read.

When should watching turn into treating?

Watching should shift toward treatment when fibroids start to interfere with health or daily life. Clinical guidelines point to a few clear triggers: bleeding heavy enough to soak through protection or cause anemia, pelvic pressure or urinary symptoms that disrupt routines, pain, rapid growth, or interference with fertility 23. Rapid enlargement, especially new growth after menopause, deserves prompt evaluation because it is uncommon 1.

According to comparative-effectiveness evidence reviewed by the Agency for Healthcare Research and Quality, a range of options — from medications that lighten bleeding to uterus-sparing procedures — can help once symptoms cross that line 3. If bleeding is the main issue, when to see a doctor for a heavy period outlines the thresholds worth acting on. The decision is rarely urgent, so there is usually time to weigh the choices.

When watchful waiting for fibroids needs a gynecologist

A clinician helps you decide whether watchful waiting still fits or whether it is time to act. A gynecologist can confirm that a growth is a fibroid, estimate its size and position, rule out other causes of bleeding, and match the monitoring rhythm to your symptoms and life stage.

If symptoms change, the same clinician can walk through the full menu of choices, from medication to procedures, and the symptoms and treatment options for uterine fibroids give a useful overview. Gale can help you prepare for that conversation.

Common questions

Fibroids rarely disappear entirely before menopause, but many stop growing or shrink once estrogen levels fall after periods stop. For that reason, a woman close to menopause with mild symptoms is often a good candidate to simply monitor rather than treat.

Almost never. The overwhelming majority of fibroids are benign, and cancerous change is rare, at fewer than 1 in 1,000. Watchful waiting does not raise that risk, though new rapid growth, especially after menopause, is a reason to be evaluated.

Growth is usually tracked through periodic pelvic exams and, when helpful, ultrasound, alongside your own notes on symptoms like heavier bleeding or new pressure. There is no fixed schedule; many people are rechecked every 6 to 12 months depending on symptoms.

It depends on fibroid size and location. Some fibroids do not affect fertility at all, while others that distort the uterine cavity can. Anyone planning pregnancy is worth discussing timing and monitoring with a clinician who can weigh the specifics.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When a monitored fibroid needs a closer look

  • Bleeding heavy enough to soak through a pad or tampon every hour, or passing large clots, is a reason to seek prompt clinician review.
  • New or worsening pelvic pressure, a growing abdomen, or trouble emptying your bladder or bowels is a reason to seek evaluation.
  • Fibroids that appear to grow quickly, or any new growth after menopause, is a reason to be seen promptly.
  • Ongoing fatigue, breathlessness, or dizziness that may signal anemia from heavy periods is a reason to have blood work checked.

This article is general health education, not medical advice. Whether watchful waiting is right for your fibroids depends on your symptoms, their size and location, and your plans, and should be decided with a gynecologist or your primary care clinician.

References

  1. 1.Office on Women's Health (U.S. HHS) (2025). Uterine fibroids. Office on Women's Health (womenshealth.gov), U.S. HHS. linkPrevalence of fibroids by age, that most cause no symptoms, that fibroids often shrink after menopause as estrogen falls, and the range of symptoms; patient-facing overview.
  2. 2.American College of Obstetricians and Gynecologists (2021). Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000004401Expectant (watchful) management is appropriate for asymptomatic or minimally symptomatic fibroids; benign nature and rarity of leiomyosarcoma; monitoring with exam and ultrasound; triggers for treatment.
  3. 3.Hartmann KE, Fonnesbeck C, Surawicz T, Krishnaswami S, Andrews JC, Wilson JE, Velez-Edwards D, Kugley S, Sathe NA (2017). Management of Uterine Fibroids (Comparative Effectiveness Review No. 195). Agency for Healthcare Research and Quality (AHRQ). PMID 30789683Comparative-effectiveness evidence that a range of medical and uterus-sparing options can treat symptomatic fibroids once symptoms warrant action.
  4. 4.National Institute for Health and Care Excellence (2026). Heavy menstrual bleeding: assessment and management (NG88). National Institute for Health and Care Excellence (NICE). linkAssessment of heavy menstrual bleeding, including checking a full blood count for anemia, and thresholds that prompt investigation.

4 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy